Logo image of BARK

BARK INC (BARK) Stock Fundamental Analysis

NYSE:BARK - New York Stock Exchange, Inc. - US68622E1047 - Common Stock - Currency: USD

0.8125  -0.01 (-1.12%)

After market: 0.82 +0.01 (+0.92%)

Fundamental Rating

3

Taking everything into account, BARK scores 3 out of 10 in our fundamental rating. BARK was compared to 121 industry peers in the Specialty Retail industry. While BARK seems to be doing ok healthwise, there are quite some concerns on its profitability. BARK is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year BARK has reported negative net income.
In the past year BARK has reported a negative cash flow from operations.
In the past 5 years BARK always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: BARK reported negative operating cash flow in multiple years.
BARK Yearly Net Income VS EBIT VS OCF VS FCFBARK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 -50M -100M -150M

1.2 Ratios

BARK has a worse Return On Assets (-12.61%) than 82.64% of its industry peers.
The Return On Equity of BARK (-33.03%) is worse than 65.29% of its industry peers.
Industry RankSector Rank
ROA -12.61%
ROE -33.03%
ROIC N/A
ROA(3y)-13.46%
ROA(5y)-15.38%
ROE(3y)-31.89%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BARK Yearly ROA, ROE, ROICBARK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 200 400 600 800

1.3 Margins

BARK has a better Gross Margin (62.37%) than 91.74% of its industry peers.
BARK's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for BARK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 62.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.91%
GM growth 5Y0.66%
BARK Yearly Profit, Operating, Gross MarginsBARK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

5

2. Health

2.1 Basic Checks

BARK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BARK has less shares outstanding
BARK has less shares outstanding than it did 5 years ago.
BARK has a worse debt/assets ratio than last year.
BARK Yearly Shares OutstandingBARK Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
BARK Yearly Total Debt VS Total AssetsBARK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

Based on the Altman-Z score of 0.26, we must say that BARK is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.26, BARK is not doing good in the industry: 77.69% of the companies in the same industry are doing better.
BARK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.26
ROIC/WACCN/A
WACC8.39%
BARK Yearly LT Debt VS Equity VS FCFBARK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

2.3 Liquidity

BARK has a Current Ratio of 1.63. This is a normal value and indicates that BARK is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.63, BARK is in the better half of the industry, outperforming 71.07% of the companies in the same industry.
BARK has a Quick Ratio of 1.63. This is a bad value and indicates that BARK is not financially healthy enough and could expect problems in meeting its short term obligations.
BARK's Quick ratio of 0.92 is fine compared to the rest of the industry. BARK outperforms 73.55% of its industry peers.
Industry RankSector Rank
Current Ratio 1.63
Quick Ratio 0.92
BARK Yearly Current Assets VS Current LiabilitesBARK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

4

3. Growth

3.1 Past

BARK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 81.82%, which is quite impressive.
Looking at the last year, BARK shows a decrease in Revenue. The Revenue has decreased by -1.22% in the last year.
The Revenue has been growing by 16.64% on average over the past years. This is quite good.
EPS 1Y (TTM)81.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-29.2%
Revenue 1Y (TTM)-1.22%
Revenue growth 3Y-1.55%
Revenue growth 5Y16.64%
Sales Q2Q%-5%

3.2 Future

BARK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 78.89% yearly.
Based on estimates for the next years, BARK will show a quite strong growth in Revenue. The Revenue will grow by 8.73% on average per year.
EPS Next Y230.92%
EPS Next 2Y153.71%
EPS Next 3Y120.15%
EPS Next 5Y78.89%
Revenue Next Year7.76%
Revenue Next 2Y9.09%
Revenue Next 3Y9.71%
Revenue Next 5Y8.73%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BARK Yearly Revenue VS EstimatesBARK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
BARK Yearly EPS VS EstimatesBARK Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 -0.2 -0.4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BARK. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 31.03, BARK can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BARK is on the same level as its industry peers.
BARK's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 22.19.
Industry RankSector Rank
PE N/A
Fwd PE 31.03
BARK Price Earnings VS Forward Price EarningsBARK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BARK Per share dataBARK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

BARK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BARK's earnings are expected to grow with 120.15% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y153.71%
EPS Next 3Y120.15%

More info and screens

0

5. Dividend

5.1 Amount

BARK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BARK INC

NYSE:BARK (6/18/2025, 8:04:01 PM)

After market: 0.82 +0.01 (+0.92%)

0.8125

-0.01 (-1.12%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)06-04 2025-06-04/amc
Earnings (Next)08-05 2025-08-05
Inst Owners44.25%
Inst Owner Change-30.19%
Ins Owners17.55%
Ins Owner Change8.53%
Market Cap142.11M
Analysts84
Price Target3.06 (276.62%)
Short Float %9.72%
Short Ratio9.94
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)72.64%
Min EPS beat(2)35.35%
Max EPS beat(2)109.93%
EPS beat(4)4
Avg EPS beat(4)764.9%
Min EPS beat(4)35.35%
Max EPS beat(4)2870.89%
EPS beat(8)8
Avg EPS beat(8)408.74%
EPS beat(12)10
Avg EPS beat(12)271.42%
EPS beat(16)12
Avg EPS beat(16)191.1%
Revenue beat(2)0
Avg Revenue beat(2)-6.34%
Min Revenue beat(2)-10.76%
Max Revenue beat(2)-1.93%
Revenue beat(4)1
Avg Revenue beat(4)-3.06%
Min Revenue beat(4)-10.76%
Max Revenue beat(4)0.74%
Revenue beat(8)1
Avg Revenue beat(8)-2.56%
Revenue beat(12)3
Avg Revenue beat(12)-1.43%
Revenue beat(16)3
Avg Revenue beat(16)-1.47%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-57.89%
EPS NQ rev (3m)-57.89%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-22.05%
Revenue NQ rev (3m)-22.05%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 31.03
P/S 0.29
P/FCF N/A
P/OCF N/A
P/B 1.43
P/tB 1.51
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)0.03
Fwd EY3.22%
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS2.77
BVpS0.57
TBVpS0.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.61%
ROE -33.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 62.37%
FCFM N/A
ROA(3y)-13.46%
ROA(5y)-15.38%
ROE(3y)-31.89%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.91%
GM growth 5Y0.66%
F-Score5
Asset Turnover1.86
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 54.87%
Cap/Sales 1.27%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.63
Quick Ratio 0.92
Altman-Z 0.26
F-Score5
WACC8.39%
ROIC/WACCN/A
Cap/Depr(3y)117.01%
Cap/Depr(5y)206.52%
Cap/Sales(3y)2.35%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)81.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-29.2%
EPS Next Y230.92%
EPS Next 2Y153.71%
EPS Next 3Y120.15%
EPS Next 5Y78.89%
Revenue 1Y (TTM)-1.22%
Revenue growth 3Y-1.55%
Revenue growth 5Y16.64%
Sales Q2Q%-5%
Revenue Next Year7.76%
Revenue Next 2Y9.09%
Revenue Next 3Y9.71%
Revenue Next 5Y8.73%
EBIT growth 1Y22.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year140.08%
EBIT Next 3Y48.31%
EBIT Next 5Y37.04%
FCF growth 1Y-377.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-216.8%
OCF growth 3YN/A
OCF growth 5YN/A